Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...
Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...
So far 70 confirmed human cases of H5N1 infection have been reported, following a widespread outbreak across bird and cattle ...
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days ...
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
The FDA has canceled an advisory committee's meeting on flu shot recommendations, raising concerns amid shifts in leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback